期刊文献+

血管紧张素转化酶基因多态性与内皮功能的研究 被引量:1

下载PDF
导出
摘要 目的 :探讨血管紧张素转化酶 (ACE)基因多态性与冠心病血管内皮功能的关系。方法 :采用多聚酶链(PCR)技术对 2 4例心肌梗死、5 6例心绞痛患者 ,6 5例正常人的 ACE基因型及血浆内皮素 (ET)、内皮源性舒张因子(EDRF/ NO)进行了检测 ,以 ET/ NO作为内皮功能指标。结果 :心肌梗死组 D等位基因频率显著高于正常对照组 ,DD型患者中的 ET/ NO比值较 型明显升高 (P<0 .0 5 )。结论 :DD型心肌梗死患者内皮功能受损较重 ,也是 DD型易患心肌梗死的可能机制之一 。
出处 《临床荟萃》 CAS 北大核心 2001年第1期10-,共2页 Clinical Focus
  • 相关文献

参考文献7

  • 1[1]Jan A.Staessen,Ji G.wang,Giuliana Gincchio,et al.The deletion insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular renal risk.J Hypertens,1997,15(12):1579-1592
  • 2[2]Mattu R.K,Edward WA,Galton DJ,et al.A DNA variant at the ACE gene locus associated with coronary artery disease in the Gaerphilly Heart Study.Circulation,1995,91:270
  • 3郑豪义,戴玉华,邱长春.血管紧张素转化酶基因的插入/缺失多态性与其血清水平及心肌梗塞的关系[J].中华心血管病杂志,1997,25(1):34-36. 被引量:27
  • 4[4]Nakai K,Itoh C,Miura Y,et al.Deletion polymorphism of the angiotensin Iconverting enzyme gene is associated with serum ACE concentration and increased risk for coronary artery disease in the Japanese.Circulation,1994,90:2199
  • 5韩启德 文允镒 等.血管生物学.动脉粥样硬化的发病机制[M].北京:北京医科大学中国协和医科大学联合出版社,1997.205-212.
  • 6[6]Tiret L,Rigat B,Visvikis S,et al.Evidence,from combined segregation and linkage analysis,that a variant of the angiotensin I converting enzyme ACE gene contrals plasma (ACE) levels.Am J Hum Genet,1992,51:197-205
  • 7[7]Costerousse O,Allegrini J,Lopez M,et al.Angiotensin I converting enzyme in human circulationg mononuclear cells:genetic polymorphism of expression in Tlymphocytes.Biochem J,1993,290:33-40

共引文献32

同被引文献14

  • 1应淑琴,徐耕,单江.冠心病介入治疗前后患者血浆P-选择素、血栓调节蛋白、纤溶酶原激活剂抑制剂-1的变化[J].中国介入心脏病学杂志,2001,9(3):135-137. 被引量:3
  • 2Zygment P M, Plane F , Paulsson M, et al. Interactions between endothelium-derived relaxing factors in the rat hepatic artery on regulation of EDHF[J].Br J Pharmacol , 1998, 124: 992..
  • 3Warner TD, Allcock GK, Corder R,et al. Use of the endothelin antagonists BD-123 and PD142893 to reveal three endothelin receptors mediating smooth nmscle contraction and the release of EDRF[J]. Br J Pharmacol,1993,110:777.
  • 4Moncada S, Higgs EA. The L-Arginine-nitric oxide and cell-cell signaling in the nervous systym[J]. Trends Neurosci, 1991,14: 60.
  • 5Boffa MC, Karmochkine M, Berant M, et al. Pllasma thrombomodulin levels in patient with non dependent diabetes mellitus [ J ]. Clin Chem, Acta, 1994,225(2):89.
  • 6Seigneur M, Dufourcq P, Conri C, et al. levels of plasma thrombomodulin are increased in atheromathous arterial disease [ J ]. Thromb Res,1993,71:423.
  • 7Blann AD, Lip GYH, Beevea,s DG, et al. Soluble P-selectin in atherosclerosis: A comparision with endothelial cell and platelet markers[J]. Thromb Haemost, 1997, 77:1077.
  • 8Fujii Y, Mammen F, Farog A, et al. Trombosis in spinal cord injury[J] .Tromb Res, 1992,68(4): 357.
  • 9Tsia YC, Chieng CH. Hemostatic molecular makers in nephritic syndrome [J]. Am J Haematol, 1993, 44(1): 276.
  • 10徐凤华,门剑龙.慢性肺原性心脏病部分凝血功能及凝血因子活化指标的测定[J].临床检验杂志,1998,16(4):247-248. 被引量:9

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部